Bloehdorn, Johannes http://orcid.org/0000-0003-1433-9702
Braun, Andrejs http://orcid.org/0000-0003-0925-5598
Taylor-Weiner, Amaro
Jebaraj, Billy Michael Chelliah
Robrecht, Sandra
Krzykalla, Julia
Pan, Heng
Giza, Adam
Akylzhanova, Gulnara
Holzmann, Karlheinz
Scheffold, Annika
Johnston, Harvey E.
Yeh, Ru-Fang
Klymenko, Tetyana
Tausch, Eugen
Eichhorst, Barbara
Bullinger, Lars
Fischer, Kirsten
Weisser, Martin
Robak, Tadeusz http://orcid.org/0000-0002-3411-6357
Schneider, Christof
Gribben, John http://orcid.org/0000-0002-8505-7430
Dahal, Lekh N. http://orcid.org/0000-0001-8390-6593
Carter, Mathew J.
Elemento, Olivier http://orcid.org/0000-0002-8061-9617
Landau, Dan A. http://orcid.org/0000-0003-2346-9541
Neuberg, Donna S. http://orcid.org/0000-0003-2566-3145
Cragg, Mark S.
Benner, Axel http://orcid.org/0000-0002-7238-6956
Hallek, Michael
Wu, Catherine J. http://orcid.org/0000-0002-3348-5054
Döhner, Hartmut
Stilgenbauer, Stephan
Mertens, Daniel
Article History
Received: 4 April 2020
Accepted: 3 August 2021
First Online: 13 September 2021
Competing interests
: S.S. received advisory board honoraria, research support, travel support, speaker fees from AbbVie, Amgen, AstraZeneca, Celgene, Gilead, GSK, Hoffmann-La Roche, Janssen, Novartis, Sunesis. O.E. is supported by Janssen, Johnson and Johnson, Volastra Therapeutics, AstraZeneca, and Eli Lilly research grants. He is a scientific advisor and equity holder in Freenome, Owkin, Volastra Therapeutics and One Three Biotech and paid scientific advisor to Champion Oncology. M.S.C. is a retained consultant for BioInvent International and has performed educational and advisory roles for Roche, Boehringer Ingelheim, Baxalta, Merck KGaA, and GLG. He has received research funding from Bioinvent, Roche, Gilead, iTeos, UCB, and GSK. He is co-inventor of patent WO2012022985A1 protecting antibodies directed to hFcgRIIB in combination with CD20 specific antibodies. L.B.: Advisory Committees Abbvie, Amgen, Astellas, Bristol-Myers Squibb, Celgene, Daiichi Sankyo, Gilead, Hexal, Janssen, Jazz Pharmaceuticals, Menarini, Novartis, Pfizer, Sanofi, Seattle Genetics. R-F.Y. and M.W. are employed by Genentech and Roche, respectively. J.B. received travel support from Janssen and research support from Roche. The remaining authors declare no competing interests.